Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.61 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.61 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NNMT | P40261 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5604568 | 0.98 | SLC22A2 (0.58) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL16711558 | 0.92 | HDAC8 (0.56) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL10680169 | 0.88 | SLC22A2 (0.65) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL12849572 | 0.80 | NNMT (0.49) | NNMTUSP2APOBEC3AAPOBEC3GSMN1; SMN2 | |
| SCHEMBL20524229 | 0.76 | TERT (0.47) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL5143707 | 0.76 | HDAC8 (0.42) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL8827505 | 0.76 | SLC22A2 (1.00) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| SCHEMBL37321 | 0.76 | SLC22A2 (1.00) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| Hydrochloric Acid SCHEMBL163494 | 0.74 | SLC22A2 (0.94) | SLC22A2SLC22A1SLC22A3SLC6A4HDAC8 | |
| Iodide SCHEMBL2203363 | 0.74 | SLC6A4 (0.94) | SLC22A2SLC22A1SLC22A3SLC6A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111363540-A | Synthesis and application of yellow fluorescent luminous silver-iodine-based hybrid | 济南大学 | 2020-07-03 | — | — | CN | claimed |
| WO-2023153906-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | 삼성에스디아이 주식회사 | 2023-08-17 | — | — | WO | disclosed |
| US-11725145-B2 | Coating-type polarizing film using diacetylene-based lyotropic liquid crystal mixture containing iodines, and manufacturing method therefor | INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY (KR) | 2023-08-15 | — | — | US | disclosed |
| WO-2023128518-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023128513-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2023-07-06 | — | — | WO | disclosed |
| CN-111363540-B | Synthesis and application of yellow fluorescent luminous silver-iodine-based hybrid | 济南大学 | 2021-04-30 | — | — | CN | disclosed |
| CN-111363540-B | Synthesis and application of yellow fluorescent luminous silver-iodine-based hybrid | 济南大学 | 2021-04-30 | — | — | CN | disclosed |
| CN-111363540-A | Synthesis and application of yellow fluorescent luminous silver-iodine-based hybrid | 济南大学 | 2020-07-03 | — | — | CN | disclosed |
| CN-111363540-A | Synthesis and application of yellow fluorescent luminous silver-iodine-based hybrid | 济南大学 | 2020-07-03 | — | — | CN | disclosed |
| CN-106661735-B | Palladium plating solution and palladium coating film obtained using the same | 日本高纯度化学株式会社 | 2019-12-10 | — | — | CN | disclosed |
| EP-1719768-B1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | ASAHI KASEI PHARMA CORP (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20120015925-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | ASAHI KASEI PHARMA CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| EP-1535913-B1 | NOVEL QUATERNARY AMMONIUM COMPOUNDS | ASAHI KASEI PHARMA CORP (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-7973030-B2 | Benzothiazepine and benzothiepine compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7803792-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-09-28 | — | — | US | disclosed |
| US-7312208-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | SLC22A2 68/4885SLC22A1 50/4885SLC22A3 49/4885 |
| US-20120015925-A1 | NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS | SLC10A1, SREBF1, SPTLC1 | SLC22A2 810/4885SLC22A1 429/4885SLC22A3 742/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | SLC22A2 813/4885SLC22A1 409/4885SLC22A3 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.